Please login to the form below
AAR
This page shows the latest AAR news and features for those working in and with pharma, biotech and healthcare.
Daily Brief: Andrew Witty's replacement on Accelerated Access initiative, Blincyto gains full EU approval and more
The latest news from across pharma, biotech and healthcare
Latest news
-
Ex-GSK head Witty to head group overseeing UK fast-track scheme
Last October, the independent Accelerated Access Review (AAR) led by Sir High Taylor set out a series of recommendations for streamlining the access process for new drugs, medical devices, diagnostics and ... In July, it kicked off the AAR implementation
-
Mixed news for pharma on UK's Accelerated Access Review
and indeed an official government response to the AAR has not yet been delivered. ... AAR’s recommendations into reality now relies on a full, positive government response to the review - and an effective life sciences industrial strategy".
-
UK pharma's contribution to NHS hits £1bn mark
The AAR was announced by Minister for Life Sciences George Freeman in November 2014 after it became apparent that plans to replace the PPRS with a value-based pricing model - along
More from news
Approximately 2 fully matching, plus 2 partially matching documents found.
Latest Intelligence
-
Lighting the way
AAR is some 'early wins'. ... The key is to pick the right winners… the AAR team are looking for innovative products that hit the sweet-spot.”.
-
Market access in Europe: balancing access and affordability
In October 2016, the Accelerated Access Review (AAR) published its recommendations to the UK government. ... The AAR speaks of 'win-win scenarios' that effectively trade market access against lower prices.
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
- HCP ENGAGEMENT STUDY: Pharma shifts top priority to HCP insights and impact metrics
- AstraZeneca/Merck’s Lynparza combination recommended by NICE for advanced ovarian cancer
- BMS shares positive phase 3 results for Opdivo/Yervoy combination in colorectal cancer
- Stanford Medicine researchers find blood tests help predict organ failure
- GSK and GCOA report reveals global inequities in adult immunisation uptake
- A “Leaky Pipeline” and the Loss of Talented Female Physicians
No results were found
PMHub
Life Healthcare Communications
Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...
Latest intelligence
- Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
- ...
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
